Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial

G B Bluhm1, J T Sharp, B C Tilley

  • 1Henry Ford Hospital, Detroit, MI 48202, USA.

The Journal of Rheumatology
|July 1, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.

European journal of neurology·2014
Same author

Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.

European journal of neurology·2013
Same author

Fall frequency and risk assessment in early Parkinson's disease.

Parkinsonism & related disorders·2012
Same author

Note: Integration of trapped ion mobility spectrometry with mass spectrometry.

The Review of scientific instruments·2012
Same author

OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials.

Osteoarthritis and cartilage·2011
Same author

The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.

Osteoarthritis and cartilage·2009

Minocycline did not significantly slow radiographic disease progression in rheumatoid arthritis patients over 48 weeks compared to placebo. While trends suggested a benefit, the study lacked power to confirm minocycline

Area of Science:

  • Rheumatology
  • Clinical Trials
  • Radiology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease.
  • Assessing radiographic progression is crucial for evaluating RA treatments.
  • Minocycline is an antibiotic with anti-inflammatory properties investigated for RA.

Purpose of the Study:

  • To evaluate the effect of minocycline on radiographic disease progression in RA patients.
  • To compare minocycline (200 mg/day) versus placebo in the 48-week Minocycline in Rheumatoid Arthritis (MIRA) Trial.

Main Methods:

  • Double-blind, randomized, multicenter trial with 219 adult RA patients.
  • Hand radiographs assessed for erosions and joint space narrowing at baseline and 48 weeks.
  • Outcomes included progression rates, newly involved joints, and newly erosive disease.

Related Experiment Videos

Main Results:

  • No significant differences in erosion or joint space narrowing progression rates between minocycline and placebo groups.
  • A trend towards fewer newly erosive joints in the minocycline group (32% vs. 44% placebo; p=0.08) was not statistically significant.
  • The study was underpowered (43%) to detect a 50% difference in progression.

Conclusions:

  • Radiographic measures did not show a significant difference between minocycline and placebo for RA progression.
  • A trend toward treatment benefit was observed, aligning with clinical findings.
  • Trial duration, measurement variability, and slow progression limited power; longer trials and comparative measure assessments are recommended.